DD
Dheer Dharmesh Shah
About Dheer Dharmesh Shah
Data last updated:
Dheer Dharmesh Shah is a Director at Bdr Lifesciences Private Limited (since 2018), Director at Virdev Intermediates Private Limited (since 2024) and Nominee Director at Cibeles Pharmaceuticals Private Limited (since 2020), and holds 4 more current directorships. The companies operate in Pharma, Healthcare and Business Services. The 4 current companies with reported revenue have a combined latest revenue of ₹330 Cr; the largest is Bdr Lifesciences Private Limited at ₹177 Cr (FY 2025). Earlier, Dheer Dharmesh Shah was a Director at Bdr Pharmaceuticals International Private Limited (2020–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 May 2018 | 1993 | ₹177 Cr (FY 2025) | Active | |
| Director | 01 Mar 2024 | 1994 | ₹108 Cr (FY 2025) | Active | |
| Nominee Director | 03 Mar 2020 | 2019 | ₹27.15 Cr (FY 2025) | Active | |
| Director | 18 Dec 2023 | 2016 | ₹17.94 Cr (FY 2025) | Active | |
| Designated Partner | 24 Feb 2022 | 2022 | Active | ||
| Designated Partner | 15 Sep 2020 | 2020 | Active | ||
| Designated Partner | 30 Jan 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Jun 2020 | 2002 | ₹1,137 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Dheer Dharmesh Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dheer Dharmesh Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dheer Dharmesh Shah
Dheer Dharmesh Shah currently holds 7 directorships: Bdr Lifesciences Private Limited (Director, since 30 May 2018, revenue ₹177 Cr (FY 2025)); Virdev Intermediates Private Limited (Director, since 01 Mar 2024, revenue ₹108 Cr (FY 2025)); Cibeles Pharmaceuticals Private Limited (Nominee Director, since 03 Mar 2020, revenue ₹27.15 Cr (FY 2025)); Spinos Life Science And Research Private Limited (Director, since 18 Dec 2023, revenue ₹17.94 Cr (FY 2025)); Bd-Verse Llp (Designated Partner, since 24 Feb 2022); and 2 more.
Dheer Dharmesh Shah was first appointed on 30 Jan 2018 as Designated Partner at Bnj Innovations Llp. The most recent appointment on record is 01 Mar 2024 at Virdev Intermediates Private Limited.
The 4 current companies of Dheer Dharmesh Shah that report revenue have a combined latest revenue of ₹330 Cr: Bdr Lifesciences Private Limited ₹177 Cr (FY 2025); Virdev Intermediates Private Limited ₹108 Cr (FY 2025); Cibeles Pharmaceuticals Private Limited ₹27.15 Cr (FY 2025); Spinos Life Science And Research Private Limited ₹17.94 Cr (FY 2025).
Dheer Dharmesh Shah held 1 earlier board appointment: Bdr Pharmaceuticals International Private Limited (Director, 18 Jun 2020 to 12 May 2022).
The current boards of Dheer Dharmesh Shah's companies include Ketan Suresh Shah (Bdr Lifesciences Private Limited), Raheel Dharmesh Shah (Bdr Lifesciences Private Limited), Sanjay Amritlal Solanki (Bdr Lifesciences Private Limited), Tejash Vijay Shah (Bdr Lifesciences Private Limited), Trushit Pramodray Mehta (Bdr Lifesciences Private Limited), Kaushik Bhagwandas Jariwala (Virdev Intermediates Private Limited), among others.